Acquisition / mergerNotableFiled on BSE ·

Entero Healthcare posts FY26 audited results; approves Vishal Surgicals acquisition

Entero Healthcare Solutions · Retailing

Arthneeti Research DeskPublished 1 min read
₹6,591 CrAcquisition / merger

Key highlights

  • Audited consolidated revenue from operations for FY26 is Rs. 65,912.12 million and consolidated profit for the year is Rs. 1,458.40 million.
  • Board approved re-appointment of Sujesh Vasudevan, Rajesh Shashikant Dalal and Sandhya Gadkari Sharma as Non-Executive Independent Directors for five years from August 25, 2026, subject to AGM shareholder approval.
  • Board approved acquisition of Vishal Surgicals and Vishal Surgicals & Medicals, a partnership firm, through subsidiary Sai Pharma Distributors Private Limited via slump sale / business transfer agreement.

Why it's rated notable: the year-on-year change is 44% (20% to 50%)

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

The Board Approved The Re-Appointment Of Internal Auditor M/S. Ernst & Young LLP ('EY') For The Next Financial Year 2026-27.

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Entero Healthcare Solutions

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.